Inhibitory effect on growth of xenograft with Wilms’ tumor by Par-4 gene sensitizing cisplatin
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To study the effects of adenovirus mediated prostate apoptosis response-4 (Par-4)combined with cisplatin(CDDP)on subcutaneous xenografts of hunan Wilms’ tumor cells SK-NEP-1 in nude mouse. Methods:Inhibition effect of subcutaneous transplanted Wilms’ tumor model were established in BALB/c nude mice,and then the nude mice were randomly divided into five groups,namely Par-4+CDDP group,Par-4 group,CDDP group,negative control Par-4 group and blank control group. The volumes and weights of the transplanted tumors were measured. Transplanted tumor tissues were used to detect the expression levels of Par-4,GRP78 and BAX protein by HE staining and immunohistochemical analysis. Results:The tumor growth was inhibited in Par-4+CDDP group,Par-4 group and CDDP group,and there were differences in the tumor weight amorg 3 groups (P < 0.05). The inhibition effect of Par-4+CDDP group was superior to the Par-4 group and CDDP group. There was no statistically significace in tumor inhibition between blank control group and negative control Par-4 group. Par-4+CDDP can significantly increased Par-4,GRP78 and BAX protein(P < 0.05). Conclusion: Ectopic Par-4 in combination with CDDP suppressed the cancer-xenografted growth in nude mice,which might up-regulate BAX protein,the result of the interraction of extracellular Par-4 and GRP78.

    Reference
    Related
    Cited by
Get Citation

Li Yunjie, Yin Liping, Lu Chao. Inhibitory effect on growth of xenograft with Wilms’ tumor by Par-4 gene sensitizing cisplatin[J].,2015,(9):1195-1199.

Copy
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:April 07,2015
  • Revised:
  • Adopted:
  • Online: September 10,2015
  • Published:
Article QR Code